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Fd DEFICIENCY AND MOLECULAH S IZE OF SCLEHOMYX-
EDE MA MONOCLONAL IMM UNOG LOBULINS 
To the Editor: 
Recenlly (11. Fd deficiency of t he monoclona l IgG-lambda immuno-
globulin has been observed in a patient with scleromyxedema. The 
molecula r weigh t of t his pa raprotein was ))0,000 da ltons. This stimu -
lated us to perform s imilar investigations in 2 cases. After purification 
of t he monoclonal immunoglobulins (both IgGI -lambda) by isoelectric 
focus ing [2J these were subjected to immunoelectrophoresis with anti -
Fd and anti- Fab ant isera (Behrinbrwerke, Marburg, F.RG .) and ana lyt-
ical ultracentrifugation. No Fd deficiency could be detected by immu -
noelectrophoresis, t he molecula r weight of monomeric immunoglobu-
lins calculated from ul tracentrifugation was approx imately 160,000 
da ltons. These resul ts are in accordance with amino acid ana lysis of 
the monoclona l immunoglobulin of an early described case with papula r 
mucinosis, which d id not show subs tant ia l differences from norma l IgG 
[3]. Th e described Fd deficiency appears to be exceptiona l and may not 
explain t he obscure skin a bnormali ties. 
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REPLY · 
We do not cons ider the Fd defect to be the cause of scleromyxedema 
a lt hough in t he case reported by us demonstra ted such a defect. As it 
is d ifferent from 2 cases reported by Kovary et a l and fur ther it 
possesses a d ifferent monoclona l immunoglobulin (the i.r 2 cases dem -
onstrate ex istence of monoclonal irpmunoglobulin at IgG I posit ion while 
ou r case had monoclona l immunoglobulin at slow position) , no com-
- parison between them is possible but we would like to point out severa l 
problematic points iT;! methods. 
. l. It seems that Fd can not a lways be sepru·ated by the purification 
of immunoglobulins through isoeleclric focus ing. It is more desi.ra ble to 
examine t he reactions of a nti-Fd, a nt i-Fab and an ti-Fc aga inst immu -
noglobulin a fter purification as well as the dete rmining molecular 
weigh t using column chromatography. 
2. In the ir 2 cases existence of stereostructura l abnormality may be 
assumed even if normal IgG I a nd molecular weight a re ident ical; t hus 
it seems necessary to examine reactions with ant i-Fd; a nti -Fab a nd 
anti-Fe aga inst monoclonal immunoglobulin treated with mercaptoeth-
a nol a fter purification. 
3. Reactions with a nt i-Fd , anti-Fab and anti-Fc should a lso be 
examined after pos t purified monoclonal immunoglobu lin has been de-
composed by papain. 
S ince we do not know the details of their methodology, it is difficul t 
to comment fur ther on t he differences between these patients. 
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S UBSTAN CE P 
T o the 8ditor: 
Drs. H agermark, Hokfe lt , and Pernow (J Inves t Dermatol 71 :233-
235, 1978) desc ri be t he induction of fl a re a nd itch by in trade rmal 
inj ection of S ubstance P (SP) in human skin. While these au thors sta te 
that SP evoked fl ar e, wh eal, and itching at the injection s ite, nowhere 
do they describe any systemic effects of such intradermal injections. 
We recen t ly injected 0.05 ml of S P intraderma Uy into t he forearms of 
7 normal vo lun teers who had provided informed consent in concentra-
tions ranging from 6.2 X 10 7 M to 2 X 10- " M a nd were surprised by the 
sys tem ic reactions we observed in a ll subjects. At t he lowest concen tra-
tions we employed , gene ra lized flushing was noted within [) min of 
injection, and this flu shing pers is ted for a bout 10 min. At higher 
concent rations, this genera lized flushing was accompanied by ext raor-
dina ry injection of t he conjunctivae and sclerae, tachycardia, diapho-
resis, and was followed within 10 min by genera lized vasocons triction 
which lasted anothe r 10-20 min. Two subjects experienced mild wheez-
ing and t igh tness in their chests, as we ll as uncomfortable abdomina l 
se nsations. Unfortunate ly, because of the unexpected nature o f these 
systemic reactions , monitoring of cardiopulm onary status was ne-
glected. All subjects recovered fully within 30 min and none required 
specia l medical attention or cardiovascular drugs such as epinephrine. 
However, a ll who received the highest concen tration of SP employed, 
described the ir reaction as being among the most unpleasant they had 
ex pe rienced. Cons idering the exceedingly sma ll dosages employed in-
tradel·mally, one must be impressed by the potency of SP as a vasodi -
la ting agent. In ligh t of such poten t e ffec ts, inadver tan t in travenous 
in t roduction of such concen trations of SP cou ld prove fa ta l. We, t here-
fore, cau tion other investigators who have read Hagermark et al'~ 
a rti cle to exercise extreme ca ut ion in injecting human subjects with S1'. 
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REPLY 
Drs. Bernstein a nd Ha mill describe l5ystemic reactions with flushing, 
tachycardia, a nd other symptoms of vasodilation after intradermal 
injection of S ubstance P (SP) . We are as surprised as they to learn 
about t his, s ince we in no case observed any s ign whatsoeve r of systemic 
e ffects after th e SP injec tions a lthough we gave as much as 10 r. M . 
However, we did no t injec t more tha n 0.02 ml and a lways in t he upper 
a rms, while Drs. Berns tein and H am ill gave 0.05 ml and in t he forearms. 
S imila r reactions as t hose described by them have previous ly been 
found to occur in humans during intravenous infusion of 81' [1]. During 
infusion of 65 to 36G ng/ min (5 X 10 " _2.8 X 10- 111 moles/min) the 
subjects described feelings of warmth and sometimes experienced tem-
poral pulsations. At the same time a bright red flush was clearly seen 
in the head and nec k a nd in isolated spots on othe r pa rts of the body 
[Il Wi thin seconds a fte r stopping the infus ions the reactions disap-
peared, which contrasts in a remarkable way from the obse rvation of 
Drs. Bernstein a nd H a mill that the flushing pers isted for about .10 milT . 
They used SP from S igma, whi le the SP used in our s tudies was 
synthesized by Prof. K Folkers, Aus tin , T exas. 
It should be added tha t we a lways perform the ini t ia l experiments 
